Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corporation - Common Stock (NQ:LQDA)

16.66 -0.36 (-2.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Liquidia Corporation - Common Stock

< Previous 1 2 3 Next >
Liquidia Corporation to Report Third Quarter 2023 Financial Results on November 7, 2023
From Liquidia Corporation
Via GlobeNewswire
Emergent BioSolutions Names Two Pharmaceutical Industry Veterans to Board of Directors
From Emergent BioSolutions
Via GlobeNewswire
FDA Accepts Submission to Add PH-ILD to YUTREPIA™ Label
From Liquidia Corporation
Via GlobeNewswire
United Therapeutics Corporation Files Lawsuit Alleging Infringement of Tyvaso Patent Already Found to Be Invalid by U.S. Patent Office
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports Second Quarter 2023 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report Second Quarter 2023 Financial Results on August 10, 2023
From Liquidia Corporation
Via GlobeNewswire
Liquidia Submits Amendment to Add PH-ILD Indication to Tentatively Approved NDA for YUTREPIA™ (treprostinil) Inhalation Powder
From Liquidia Corporation
Via GlobeNewswire
U.S. Federal Circuit Affirms All District Court Rulings in Patent Litigation
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation and Pharmosa Biopharm Announce Collaboration for Sustained-Release Inhaled Treprostinil Product in North America
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at the 2023 Jefferies Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Announces Poster Presentation at the 2023 American Thoracic Society International Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports First Quarter 2023 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at BofA Securities 2023 Health Care Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report First Quarter 2023 Financial Results on May 4, 2023
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia and GSK Restructure License to PRINT Technology for Inhaled Applications
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports Full Year 2022 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report Full Year 2022 Financial Results on Thursday, March 16, 2023
From Liquidia Corporation
Via GlobeNewswire
Patent Trial and Appeal Board (PTAB) Reaffirms Decision to Invalidate All Claims of United Therapeutics (UTHR) Patent No. 10,716,793 (‘793 Patent)
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
From Liquidia Corporation
Via GlobeNewswire
Liquidia Enters Into a Revenue Interest Financing Agreement With HealthCare Royalty for Up to $100 Million
From Liquidia Corporation
Via GlobeNewswire
Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)
From Liquidia Corporation
Via GlobeNewswire
Liquidia Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Company to host webcast and conference call today at 8:30 a.m. ET 
From Liquidia Corporation
Via GlobeNewswire
Liquidia to Report Third Quarter 2022 Financial Results on November 8, 2022
From Liquidia Corporation
Via GlobeNewswire
Precedential Opinion Panel Denies United Therapeutics’ Request for Review of ‘793 Inter Partes Review Decision
From Liquidia Corporation
Via GlobeNewswire
Liquidia Announces Presentations at the CHEST 2022 Annual Meeting
From Liquidia Corporation
Via GlobeNewswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.